BUSINESS / MARKETS / POLITICS9 November 2026
← Story archive

Business

A failed trial for a heart drug casts shadow over rivals developing similar therapies

MarketWatch

The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

Read original reporting ↗

Follow the evidence

Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.

Coverage timeline

Published reporting in time order

Some related stories are temporarily unavailable.

This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →